BZBrian ZanoniMD, MPHSlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #9 Mental Health Challenges and Substance Use Associated with Poor Viral Suppression and Transition Readiness among Adolescents with HIV Transitioning to Adult Care - Brian ZanoniView Slideset
BZBrian ZanoniMD, MPHVideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #9 Mental Health Challenges and Substance Use Associated with Poor Viral Suppression and Transition Readiness among Adolescents with HIV Transitioning to Adult Care - Brian ZanoniView Video
SlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #10 Outcomes of Children and Young Adolescents Receiving ART Under Family-Based DSD Model at Largest Public ART Clinic in Lilongwe, Malawi - Petros P.M. TemboView Slideset
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #10 Outcomes of Children and Young Adolescents Receiving ART Under Family-Based DSD Model at Largest Public ART Clinic in Lilongwe, Malawi - Petros P.M. TemboView Video
MMMauricio MartinsBSc, PhDSlidesetHIV17th International Workshop on Pediatrics & HIV 2025 Gene Therapy and Remission - Mauricio MartinsView Slideset
MMMauricio MartinsBSc, PhDVideoHIV17th International Workshop on Pediatrics & HIV 2025 Gene Therapy and Remission - Mauricio MartinsView Video
SlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #11 Predictors of Treatment Failure in Children Living with HIV Starting First-Line Antiretroviral Therapy in the ODYSSEY Trial - James WyncollView Slideset
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #11 Predictors of Treatment Failure in Children Living with HIV Starting First-Line Antiretroviral Therapy in the ODYSSEY Trial - James WyncollView Video
SlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #12 Factors Associated with HIV-1 DNA Dynamics in Early Treated Children with Perinatal HIV - Alfredo Tagarro GarciaView Slideset
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #12 Factors Associated with HIV-1 DNA Dynamics in Early Treated Children with Perinatal HIV - Alfredo Tagarro GarciaView Video
HMHilda MujuruMBChB, MMed Paeds, MSc Clin EpiSlidesetHIV17th International Workshop on Pediatrics & HIV 2025Abstract #13 Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide (F/TAF) Plus Cobicistat-Boosted Protease Inhibitors in Children with HIV-1 Aged 2-<12 Years and Weighing 14-<40 kg: Week 48 Outcomes - Hilda Angela MujuruView Slideset
HMHilda MujuruMBChB, MMed Paeds, MSc Clin EpiVideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #13 Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide (F/TAF) Plus Cobicistat-Boosted Protease Inhibitors in Children with HIV-1 Aged 2-<12 Years and Weighing 14-<40 kg: Week 48 Outcomes - Hilda Angela MujuruView Video
